You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR BECONASE AQ


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BECONASE AQ

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00115089 ↗ 7 Day Study of Mast Cell Inhibitor, R926112, in Patients With Symptomatic Seasonal Allergic Rhinitis Completed Rigel Pharmaceuticals Phase 2 2005-07-01 This is a study of the effectiveness and safety of a new nasal spray for the relief of the symptoms of seasonal allergies. The agents being compared are: R926112 (a novel anti-allergy medicine), Beconase (beclomethasone dipropionate, an established FDA approved steroid treatment), and an inactive placebo. The study hypothesis is that R926112 will be superior to placebo at the end of a week of testing and evaluation. The study does not have the power to determine how R926112 compares to Beconase.
NCT00489203 ↗ Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed Fred Hutchinson Cancer Research Center Phase 2 2007-04-01 RATIONALE: Beclomethasone dipropionate may be effective in preventing acute graft-versus-host disease in patients undergoing a stem cell transplant for hematologic cancer. PURPOSE: This randomized phase II trial is studying how well beclomethasone dipropionate works in preventing acute graft-versus-host disease in patients undergoing a donor stem cell transplant for hematologic cancer.
NCT00775489 ↗ Nasal Steroids in Controlled Glaucoma Completed Glaucoma Research Society of Canada N/A 2010-01-01 Patients that have consented to participate in the study will be randomly assigned to one of two groups: control group or nasal steroid group. Patients in the control group will receive normal saline inhaler. Patients in the study group will receive steroid inhaler Follow-up visits are: baseline and weeks 2, 4, 6 after starting the spray. Intraocular pressure will be recorded on all visits.
NCT00775489 ↗ Nasal Steroids in Controlled Glaucoma Completed University Health Network, Toronto N/A 2010-01-01 Patients that have consented to participate in the study will be randomly assigned to one of two groups: control group or nasal steroid group. Patients in the control group will receive normal saline inhaler. Patients in the study group will receive steroid inhaler Follow-up visits are: baseline and weeks 2, 4, 6 after starting the spray. Intraocular pressure will be recorded on all visits.
NCT01550471 ↗ Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis Completed West Penn Allegheny Health System Phase 4 2012-03-01 This study will provide the clinicians guidance on the safest combination of inhaled and nasal corticosteroids for children with mild asthma and allergic rhinitis respectively; however, one safety concern is that these products are independently known to have dose-related effects on short term and intermediate term growth. Knemometry is a non invasive technique for measuring short-term lower leg growth in children and is currently the method of choice in growth studies of short duration. Subjects will be seen on a weekly basis for 18 weeks and at each visit, lower leg length will be measured using knemometry.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BECONASE AQ

Condition Name

Condition Name for BECONASE AQ
Intervention Trials
Refractory Hairy Cell Leukemia 1
Childhood Acute Myeloid Leukemia in Remission 1
Stage III Adult Diffuse Small Cleaved Cell Lymphoma 1
Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BECONASE AQ
Intervention Trials
Rhinitis, Allergic 2
Rhinitis 2
Leukemia, Myeloid, Chronic-Phase 1
Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BECONASE AQ

Trials by Country

Trials by Country for BECONASE AQ
Location Trials
United States 3
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for BECONASE AQ
Location Trials
Pennsylvania 1
Washington 1
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BECONASE AQ

Clinical Trial Phase

Clinical Trial Phase for BECONASE AQ
Clinical Trial Phase Trials
Phase 4 1
Phase 2 2
N/A 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BECONASE AQ
Clinical Trial Phase Trials
Completed 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BECONASE AQ

Sponsor Name

Sponsor Name for BECONASE AQ
Sponsor Trials
West Penn Allegheny Health System 1
Rigel Pharmaceuticals 1
Fred Hutchinson Cancer Research Center 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BECONASE AQ
Sponsor Trials
Other 4
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.